Regarding the role of IFN-γ in activating MSCs, it could be demonstrated, that MSCs primed with IFN-γ were able to reduce GVHD in NOD-SCID mice and to ameliorate survival rates when compared to animals receiving non-primed MSCs. The gene discussed is IFNG; the disease is graft versus host disease.